Laurus Labs Limited specializes in Pharmaceuticals within the Healthcare sector.
Laurus Labs Limited, with Security Code 540222, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
---|---|---|---|---|---|---|---|---|---|
2024-01-01 | 2024-03-31 | 14,396.70 | 750.20 | 14,582.00 | 1.40 | -3,150.60 | 185.30 | -1,022.50 | 1,072.70 |
2024-01-01 | 2024-03-31 | 14,145.20 | 1,213.20 | 14,386.10 | 2.25 | -2,890.30 | 240.90 | -889.00 | 1,643.10 |
2023-10-01 | 2023-12-31 | 11,321.90 | 426.40 | 11,429.10 | 0.79 | -2,924.70 | 107.20 | -868.40 | 567.00 |
2023-10-01 | 2023-12-31 | 11,949.20 | 233.40 | 11,973.50 | 0.43 | -3,131.30 | 24.30 | -984.10 | 346.20 |
Compounded Sales Growth | |
---|---|
10 Years: | 15% |
5 Years: | 17% |
3 Years: | 0% |
TTM: | -17% |
Compounded Profit Growth | |
---|---|
10 Years: | 9% |
5 Years: | 19% |
3 Years: | -38% |
TTM: | -71% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | 44% |
3 Years: | -14% |
1 Year: | 23% |
Compounded Sales Growth | |
---|---|
10 Years: | 16% |
5 Years: | 17% |
3 Years: | 2% |
TTM: | -17% |
Compounded Profit Growth | |
---|---|
10 Years: | 5% |
5 Years: | 11% |
3 Years: | -45% |
TTM: | -80% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | 44% |
3 Years: | -14% |
1 Year: | 23% |